Patient satisfaction and allergen immunotherapy.
Although health-related quality of life and patient satisfaction are shifting doctors' attention to the patient, the scant number of publications on quality of life questionnaires and allergen immunotherapy contrasts with the quickly growing number of those dealing with this topic and pharmacotherapy. We delivered an original, self-administered patient satisfaction questionnaire to 95 patients (age = 17.7 +/- 7.9 years) suffering from allergic rhinoconjunctivitis (45%) and/or asthma (55%), who had been receiving allergen immunotherapy for more than 1 year (22.2 +/- 10.5 months). The anonymous, voluntary questionnaire was filled in at home; although only 32% were returned, we found no significant differences relating to age, sex, asthma, allergen sensitization or allergen immunotherapy regimen between the source sample and those who replied. Patient expectations, which were scored on a scale of 1 to 10 points, were rather poor, in sharp contrast with patient perception score after treatment (5.4 +/- 1.8 vs. 8.0 +/- 2.0, p < 0.0001). Perception scores did not differ between patients receiving seasonal or perennial allergen immunotherapy, nor did they depend on the duration of treatment. In addition, patient age, sex, diagnosis or sensitization did not appear to influence perceptions. In conclusion, our data suggest that when a voluntary, anonymous questionnaire is used, patients express a poor opinion of allergen immunotherapy, in contrast with high satisfaction after treatment, provided that allergen immunotherapy lasts long enough.
Gozalo Reques
F
F
Allergology Section, Hospital deLeon, Spain.
Estrada Rodríguez
J L
JL
Martín Hurtado
S
S
Alvarez Cuesta
E
E
D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000627:therapeutic use*; D002648:Child; D003625:Data Collection; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D017060:Patient Satisfaction; D012130:Respiratory Hypersensitivity / Q000628:therapy*
D000485:Allergens